Could novel immune cell therapy combat hepatitis B infections?
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Findings from the largest UK study of patients hospitalized with SARS-CoV-2 infection show that long COVID leads to ongoing inflammation which can be detected in the blood.
Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections. The finding, published in the journal, Immunity, may lead to earlier intervention and possibly prevention …
In a transformative study published in the journal Science Translational Medicine, an international team of researchers has made a significant breakthrough in the understanding and potential treatment of multiple sclerosis (MS).
Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could provide more accurate diagnosis and prognosis of sepsis, as well as help to target specific therapies at pa…
UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of COVID-19, long COVID, and possi…
It is currently unclear where T cells in the brains of teleosts originate from. While viewing the central nervous system (CNS) as immune privileged has been widely accepted, previous studies suggest that T cells residing in the thymus but not in the sp…
Researchers at the New England Regional Center of Vector-Borne Diseases at the University of Massachusetts Amherst have come up with a new, more accurate method for detecting in ticks the emerging Powassan virus, which can cause life-threatening neuroi…
SARS-CoV-2 has rampantly spread around the globe and continues to cause unprecedented loss through ongoing waves of (re)infection. Increasing our understanding of the protection against infection with SARS-CoV-2 is critical to ending the pandemic.
A research team led by the United States Army Medical Research Institute of Infectious Diseases, or USAMRIID, that includes Scott Pegan at the UC Riverside School of Medicine has discovered an important protective antibody target against Crimean-Congo …